ReviewCancers2026

Preoperative PARP Inhibitors in Ovarian Cancer Trials: Connecting Molecular Oncology and Cytoreductive Surgery.

Cezary Miedziarek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.